• CARMIS-Studie, Piermarocchi S, Saviano et al., 2012
  • LAST-Studie, Richer, Stiles, Statkute et al., 2001
  • LUNA-Studie, Tierschmann, Heinen, Hense, Spital et al., 2006
  • LUTEGA-Studie, S. Jentsch, D. Schweitzer, M. Hammer, J. Dawczynski, 2011
  • Glare Disability, Photostress Recovery, and Chromatic Contrast: Relation to Macular Pigment and Serum Lutein and Zeaxanthin, Billy R. Hammond Jr, Laura M. Fletcher, and James G. Elliott, Investigative Ophthalmology & Visual Science, 2013
  • A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast, Hammond B., Fletcher L., Roos F., Wittwer J., Schalch W., Vision Sciences and Human Biofactors Laboratories, Department of Psychology, University of Georgia, Athens, Georgia, United States, 2014
  • Macular pigment and healthy vision, Optometry; 2009 Oct;80(10):592-8. doi: 10.1016/j.optm.2009.08.002.
  • The Blue Mountains Eye Study: Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration, Rochtchina,E.; Wang,J.J.; Flood,V.M.; Mitchell,P , Am. J Ophthalmol. 2007, 143: 344-346.
  • Improvement of visual functions and fundus alteration in early age-related macular degeneration treated with a combination of Acetyl-L-Carnitine, n-3 fatty acids, and Coenzyme Q10, J. Feher et al., 2005, Ophtalmol. 219, 154-166.